Stephanie Kay Dudley, LCSW-C | |
2336 Goddard Pkwy, Salisbury, MD 21801-1126 | |
(410) 334-6961 | |
(410) 334-6362 |
Full Name | Stephanie Kay Dudley |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 12 Years |
Location | 2336 Goddard Pkwy, Salisbury, Maryland |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235487059 | NPI | - | NPPES |
522156095 | Other | MD | COMMERCIAL INS |
7840093 | Other | MD | AETNA |
R968 | Other | MD | CAREFIRST HMO |
609550001 | Medicaid | MD | |
346646 | Other | MHN/TRICARE | |
LM49EA | Other | MD | CAREFIRST LOCAL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 18380 (Maryland) | Primary |
1041S0200X | Social Worker - School | 18380 (Maryland) | Secondary |
104100000X | Social Worker | 18380 (Maryland) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Community Behavioral Health Llc | 2567693849 | 10 |
News Archive
A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.
Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.
Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women.
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Big tests await the health law, including whether premiums and other consumer costs can be held down in the face of pent up demand and also the GOP's continuing efforts to sabotage or repeal it heading into the midterm elections.
› Verified 6 days ago
Entity Name | Eastern Shore Psychological Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881781508 PECOS PAC ID: 5294729950 Enrollment ID: O20040414000564 |
News Archive
A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.
Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.
Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women.
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Big tests await the health law, including whether premiums and other consumer costs can be held down in the face of pent up demand and also the GOP's continuing efforts to sabotage or repeal it heading into the midterm elections.
› Verified 6 days ago
Entity Name | Community Behavioral Health Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215275466 PECOS PAC ID: 2567693849 Enrollment ID: O20140429000721 |
News Archive
A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.
Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.
Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women.
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Big tests await the health law, including whether premiums and other consumer costs can be held down in the face of pent up demand and also the GOP's continuing efforts to sabotage or repeal it heading into the midterm elections.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Stephanie Kay Dudley, LCSW-C 2336 Goddard Pkwy, Salisbury, MD 21801-1126 Ph: (410) 334-6961 | Stephanie Kay Dudley, LCSW-C 2336 Goddard Pkwy, Salisbury, MD 21801-1126 Ph: (410) 334-6961 |
News Archive
A new -7.1 million grant will enable experts from a range of institutions to come together for the first time as the Commonwealth Eye Health Consortium, coordinated by the International Centre for Eye Health at the London School of Hygiene & Tropical Medicine.
Genentech, a member of the Roche Group, today announced that preliminary results from the ADACTA (ADalimumab ACTemrA) study showed that patients who received ACTEMRA (tocilizumab) as monotherapy achieved a significantly greater reduction in disease activity after 24 weeks than those given adalimumab monotherapy.
Results of the NIH-AARP Diet and Health Study revealed that diabetes is associated with lower risk of prostate cancer in men but with higher risk of other cancers in both men and women.
Kamada, Ltd., a biopharmaceutical company engaged in development, production and marketing of specialty life-saving therapeutics and Baxter International Inc., a global, diversified healthcare company announced today that they have entered into an exclusive distribution and manufacturing agreement for Kamada's liquid, ready to use, intravenous Alpha-1 Antitrypsin Product for the treatment of hereditary Alpha-1 Antitrypsin Deficiency approved by the USFDA on July 1st, 2010 for marketing under the trade name "Glassia™".
Big tests await the health law, including whether premiums and other consumer costs can be held down in the face of pent up demand and also the GOP's continuing efforts to sabotage or repeal it heading into the midterm elections.
› Verified 6 days ago
Mr. Mark Stephen Simulis, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1104 Healthway Dr, Salisbury, MD 21804 Phone: 410-219-5483 Fax: 410-219-5486 | |
Connie G Polovina, LCSW- C Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1201 Pemberton Dr Ste 1c, Salisbury, MD 21801 Phone: 410-845-1645 Fax: 443-944-8252 | |
Farah Vangenderen, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 31413 Winterplace Pkwy Ste 102, Salisbury, MD 21804 Phone: 410-742-3055 Fax: 443-944-0095 | |
Jeffrey J Byrne, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1003 Bayshore Ct, Salisbury, MD 21804 Phone: 443-614-8777 | |
Penny Sue Walters, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 26916 Siloam Rd, Salisbury, MD 21801 Phone: 410-603-2807 | |
Mrs. Kirsten Allen Culler, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 111 W Main St, Suite E, Salisbury, MD 21801 Phone: 443-736-4114 Fax: 443-736-7982 | |
Ms. Sharon Lynn Janssen, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 560 Riverside Dr Ste A204, Salisbury, MD 21801 Phone: 443-358-6193 Fax: 443-358-6197 |